Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA)

54 filings reported holding CNTA - Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share as of Q4 2021.
Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 71,873,880 shares of 147,336,360 outstanding shares and own 48.78% of the company stock.
Largest 10 shareholders include Medicxi Ventures Management (Jersey) Ltd (18,123,892 shares), Index Venture Life Associates VI Ltd (9,961,789 shares), GENERAL ATLANTIC, L.P. (9,681,818 shares), JANUS HENDERSON GROUP PLC (5,743,397 shares), Vida Ventures Advisors, LLC (3,931,818 shares), RA CAPITAL MANAGEMENT, L.P. (3,577,094 shares), Cormorant Asset Management, LP (2,489,894 shares), OUP Management Co., LLC (2,341,891 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,076,770 shares), and Samsara BioCapital, LLC (1,459,693 shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.